ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 7 Key Findings From A Clinical Trial Operations Technology Survey

  To stay competitive in the clinical research field, sites, sponsors, and CROs need to invest in remote technology. Discover seven key trends that your clinical trial team needs to know about.

• Harnessing The Power of Real-World Data In Clinical Trial Planning

  As the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.

• Reflections From ISOQOL Conference 2024

  Greta van Schoor attended the 31st Annual ISOQOL Conference, where HRQOL leaders shared insights on optimizing eCOA collection, integrating PROs, and digital health in clinical research.

• eCOA 101: What Is Electronic Clinical Outcome Assessment?

  Electronic Clinical Outcome Assessment (eCOA) has transformed data collection in clinical trials by prioritizing patient engagement and improving data accuracy.

• Headed Down Registry Road? Here Are The EDC Features You'll Need

  Most of us rely on electronic data capture (EDC) to help us reach our study destination. How do we choose the EDC "vehicle" that will get us there safely, with minimal delays? Consider the relative importance of these key EDC features.

• The Hidden Cost Of Preferred Vendors

  Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.

• Benefits Of Using ePRO In Early Phase Studies

  Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.

• Data Visualization For Clinical Operations: Transforming Insights Into Action

  Data visualization transforms complex clinical trial data into actionable insights, significantly aiding in decision-making and trial management.

• RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk

  This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

• Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection

  Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.